Development and scale-up of a microsphere protein delivery system

Biotechnology Progress

Volumn 14, Issue 1, 1998, Pages 108-115

  Tracy, Mark A ^a  

^a ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONES; PROTEINS; TOXICITY;

MICROSPHERE PROTEIN DELIVERY SYSTEMS;

CONTROLLED DRUG DELIVERY;

HUMAN GROWTH HORMONE; MICROSPHERE;

ANIMAL; ARTICLE; BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; DRUG STABILITY; HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL;

ANIMALS; BIOTECHNOLOGY; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMAN GROWTH HORMONE; HUMANS; MICROSPHERES;

ANIMALIA;

EID: 0031908630     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp9701271     Document Type: Article

References (34)

1. Langer, R. New Methods of Drug Delivery. Science 1990, 249, 1527-1533.
2. Ogawa, Y.; Okada, H.; Yamamoto, M.; Shimamoto, T. In Vivo Release Profiles of Leuprolide Acetate from Microcapsules Prepared with Polylactic Acids or Coploy(Lactic/Glycolic) Acids and in Vivo Degradation of These Polymers. Chem. Pharm. Bull. 1988, 36, 2576-2581.
3. Ogawa, Y.; Yamamoto, M.; Okada, H.; Yashiki, T.; Shimamoto, T. A New Technique to Efficiently Entrap Leuprolide Acetate into Microcapsules of Polylactic Acid or Copoly(Lactic/Glycolic) Acid. Chem. Pharm. Bull. 1988, 36, 1095-1103.
4. Ogawa, Y.; Yamamoto, M.; Takada, S.; Okada, H.; Shimamoto, T. Controlled-Release of Leuprolide Acetate from Polylactic Acid or Copoly(Lactic/Glycolic) Acid Microcapsules: Influence of Molecular Weight and Copolymer Ratio of Polymer. Chem. Pharm. Bull. 1988, 36, 1502-1507.
5. Physicians' Desk Reference; Medical Economics Data: Montvale, NJ, 1996; pp 1061-1064, 2555-2562, 2858-2861.
6. Cleland, J. L.; Mac, A.; Boyd, B.; Yang, J.; Duenas, E. T.; Yeung, D.; Brooks, D.; Hsu, C.; Chu, H.; Mukku, V.; Jones, A. J. S. The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres. Pharm. Res. 1997, 14, 420-425.
7. Cleland, J. L.; Jones, A. J. S. Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Microspheres. Pharm. Res. 1996, 13, 1464-1475.
8. Morlock, M.; Koll, H.; Winter, G.; Kissel, T. Microencapsulation of rh-Erythropoietin, Using Biodegradable Poly(D,L-lactide-co-glycolide): Protein Stability and the Effects of Stabilizing Excipients. Eur. J. Pharm. Biopharm. 1997, 43, 29-36.
9. Gombotz, W. R.; Healy, M.; Brown, L. Very Low-Temperature Casting of Controlled Release Microspheres. U.S. Patent No. 5019400, 1991.
10. Johnson, O. L.; Cleland, J. L.; Lee, H. J.; Charnis, M.; Duenas, E.; Jaworowicz, W.; Shepard, D.; Shahzamani, A.; Jones, A. J. S.; Putney, S. D. A Month-Long Effect from a Single Injection of Microencapsulated Human Growth Hormone. Nat. Med. 1996, 2, 795-799.
11. Pearlman, R.; Bewley, T. A. Stability and Characterization of Human Growth Hormone. In Stability and Characterization of Protein and Peptide Drugs: Case Histories; Yang, Y. J., Pearlman, R., Eds.; Plenum Press: New York, 1993; pp 1-58.
12. Johnson, O. L.; Jaworowicz, W.; Cleland, J. L.; Bailey, L.; Charnis, M.; Duenas, E.; Wu, C.; Shepard, D.; Magil, S.; Last, T.; Jones, A. J. S.; Putney, S. D. The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres. Pharm. Res. 1997, 14, 730-735.
13. International Conference on Harmonization; Draft Guideline on Impurities: Residual Solvents; Availability; Notice. Fed. Regist. 1997, 62 (May 2), 24302-24309.
14. Cunningham, B. C.; Mulkerrin, M. G.; Wells, J. A. Dimerization of Human Growth Hormone by Zinc. Science 1991, 253, 546-548.
15. Langer, R.; Folkman, J. Polymers for the Sustained Release of Proteins and Other Macromolecules. Nature 1976, 263, 797-800.
16. Bawa, R.; Siegel, R.; Marasca, B.; Karel, M.; Langer, R. An Explanation for the Controlled Release of Macromolecules from Polymers. J. Controlled Release 1985, 1, 259-267.
17. Hsu, T.; Langer, R. Polymers for the Controlled Release of Macromolecules: Effect of Molecular Weight of Ethylenevinyl Acetate Copolymer. J. Biomed. Mater. Res. 1985, 19, 445-460.
18. Saltzman, W. M.; Langer, R. Transport Rates of Proteins in Porous Materials with Known Microgeometry. Biophys. J. 1989, 55, 163-171.
19. Shah, S. S.; Cha, Y.; Pitt, C. G. Poly(glycolic acid-co-DL-lactic acid): Diffusion or Degradation Controlled Drug Delivery. J. Controlled Release 1992, 18, 261-270.
20. Tracy, M. A. unpublished data, 1997.
21. Zhang, Y.; Zale, S.; Alukonis, L.; Bernstein, H. Effects of Metal Salts on PLGA Hydrolysis. Proc. Int. Symp. Controlled Release Bioact. Mater. 1995, 22, 83-84.
22. Zhang, Y.; Zale, S.; Sawyer, L.; Bernstein, H. Effects of Metal Salts on Poly(DL-lactide-co-glycolide) Polymer Hydrolysis. J. Biomed. Mater. Res. 1997, 34, 531-538.
23. Tracy, M. A.; Firouzabadian, L.; Zhang, Y. Effects of PLGA End Groups on Degradation. Proc. Int. Symp. Controlled Release Bioact. Mater. 1995, 22, 786-787.
24. Athanasiou, K. A.; Niederauer, G. G.; Agrawal, C. M. Sterilization, Toxicity, Biocompatibility and Clinical Applications of Polylactic Acid/Polyglycolic Acid Copolymers. Biomaterials 1996, 17, 93-102.
25. Visscher, G. E.; Robinson, R. L.; Maulding, H. V.; Fong, J. W.; Pearson, J. E.; Argentieri, G. J. Biodegradation of and Tissue Reaction to 50:50 Poly(DL-lactide-co-glycolide) Microcapsules. J. Biomed. Mater. Res. 1985, 19, 349-65.
26. Hutchinson, F. G.; Burr, B. J. A. Biodegradable Carriers for the Sustained Release of Polypeptides. Trends Biotechnol. 1987, 5, 102-106.
27. Tracy, M. A.; Zhang, Y.; Verdon, S. L.; Dong, N.; Riley, M. G. I. In Vivo and In Vitro Degradation of Poly(lactide-co-glycolide) Microspheres. Proc. Int. Symp. Controlled Release Bioact. Mater. 1997, 24, 623-24.
28. Mathews, L. S.; Norstedt, G.; Palmiter, R. D. Regulation of Insulin-like Growth Factor I Gene Expression by Growth Hormone. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 9343-9347.
29. Lee, H. J.; Riley, G.; Johnson, O. L.; Cleland, J. L.; Kim, N.; Charnis, M.; Bailey, L.; Duenas, E.; Shahzamani, A.; Marian, M.; Jones, A. J. S., Putney, S. D. In Vivo Characterization of Sustained-Release Formulations of Human Growth Hormone. J. Pharm. Exp. Ther. 1997, 281, 1431-1439.
30. Li, C. H.; Lahm, H. W.; Stein, S. The Primary Structure of Monkey Pituitary Growth Hormone. Arch. Biochem. Biophys. 1986, 245, 287-91.
31. Vance, M. L.; Woodburn, C. J.; Putney, S. D.; Grous, J.; Lee, H. J.; Johnson, O. L. Effects of Sustained Release Growth Hormone on Serum GH, IGF-I, and IGFBP-3 Concentrations in GH Deficient Adults. Endocrinol. Metab. 1997, 4 (Suppl. A), 75.
32. Hardouin, S.; Gourmelen, M.; Noguiez, P.; Seurin, D.; Roghani, M.; Le Bouc, Y.; Povoa, G.; Merimee, T. J.; Hossenlopp, P.; Binoux, M. Molecular Forms of Serum Insulin-like Growth Factor (IGF)-Binding Proteins in Man: Relationships with Growth Hormone and IGFs and Physiological Significance. J. Clin. Endocrinol. Metab. 1989, 69, 1291-1301.
33. Herbert, P.; Murphy, K.; Johnson, O. L.; Jaworowicz, W.; Tracy, M. A.; Cleland, J. L.; Putney, S. D. A Large Scale Process to Produce Microencapsulated Proteins. Pharm. Res., in press.
34. Croll, D. B. Barrier Technology in a Biotechnology Research and Development Environment. In Compte Pendu des Communications; Association pour les Produits Parentaux et Stériles: Congres de Bourdeaux 1996, October 16-18, 1996; pp 111-114.